LIWANLI Innovation Co., Ltd.
Research LIWANLI Innovation Co., Ltd. (3054.TW) on Bullrun: market cap TWD 4.57B, P/E 11.8, dividend yield 1.4%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker3054.TW
- ExchangeTW
- CountryTaiwan
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyTWD
- Market capTWD 4.57B
- P/E11.8
- Dividend yield1.4%
- Financial periodQ2 2026
- RevenueTWD 203.44M
- Net incomeTWD 120.22M
- Free cash flowTWD 164.20M
- Gross margin39.4%
Valuation Snapshot
latest market cap is TWD 4.57B; P/E is 11.8; dividend yield is 1.4%.
Peer valuation comparison
Latest P/E is 11.76x versus a Healthcare sector median of 21.8x (46.0% below).
Latest dividend yield is 1.36% versus a Healthcare sector median of 2.4% (43.3% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 4.57B | 11.8 | 1.4% | 0.8 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.8 TWD, yield 1.4%.
About LIWANLI Innovation Co., Ltd.
LIWANLI Innovation Co., Ltd. operates in the biomedical science industry in Taiwan and internationally. The company offers Vigoway and powder collection products for males, females, the elderly, and children. Its products include black elderberry powder, probiotic enzymes, oral care tablets, resveratrol red grape extract, e-soothing powder, tooth guard tablets, bovine and goat's milk bites, bilberry tablets, drops, and other products. The company was formerly known as Carry Technology International Co., Ltd.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is LIWANLI Innovation Co., Ltd.'s market cap?
LIWANLI Innovation Co., Ltd.'s market capitalization is TWD 4.57B.
What is LIWANLI Innovation Co., Ltd.'s P/E ratio?
LIWANLI Innovation Co., Ltd.'s price-to-earnings (P/E) ratio is 11.8.
Does LIWANLI Innovation Co., Ltd. pay a dividend?
LIWANLI Innovation Co., Ltd. has a dividend yield of 1.4%.
What does LIWANLI Innovation Co., Ltd. do?
LIWANLI Innovation Co., Ltd. operates in the biomedical science industry in Taiwan and internationally. The company offers Vigoway and powder collection products for males, females, the elderly, and children. Its products include black elderberry powder, probiotic enzymes, oral care tablets, resveratrol red grape extract, e-soothing powder, tooth guard tablets, bovine and goat's milk bites, bilberry tablets, drops, and other products. The company was formerly known as Carry Technology International Co., Ltd. and changed its name to LIWANLI Innovation Co., Ltd. in 2015.